MEIHUA BIO、MeiHua Group(SH:600873) Xin Lang Cai Jing·2026-01-14 13:25Group 1 - The core viewpoint of the article is that Meihua Biological (600873.SH) announced a plan for its directors, senior management, and other key personnel to increase their shareholding in the company, reflecting confidence in its future development and long-term investment value [1] - A total of 76 members of the management team will participate in this share buyback plan, which aims to stabilize the capital market and enhance investor confidence [1] - The share buyback is set to commence on January 14, 2026, and will last for a maximum of 12 months, concluding by January 13, 2027 [1] Group 2 - The total amount planned for the share buyback is between RMB 303.75 million and RMB 350.15 million, including transaction costs [1] - The purchase price for the shares will be determined based on market conditions, and there is no upper limit set for the buyback price [1]